| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d78cd2835221849f6a74e6349185819 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 |
| filingDate |
1990-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_002d00f4c036453cf61b526eb80a126e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c628c1af713df14ccb6f2f06eed504d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17ed6b87c9ee352ec89b03b6bc4ee336
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e8ba5876fc5f80215fb630d84003db5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dfbe6cf764b8263f3fa1f80eda0c2b8 |
| publicationDate |
1991-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H035480-A |
| titleOfInvention |
Azaindene, its production, therapeutic agent of hypertension and congestive heart disease containing such azaindene and intermediate |
| abstract |
The invention concerns azaindenes of the formula I <CHEM> (and their physiologically acceptable salts), together with pharmaceutical compositions containing them. The azaindenes antagonise the actions of angiotensin II and are of value in treating conditions such as hypertension and congestive heart failure. The invention further includes processes for the manufacture of the compounds and their use in medical treatment. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5608068-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5554757-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5557002-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0597851-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5559236-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9204343-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5583229-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5587504-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5700938-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04327586-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5618969-A |
| priorityDate |
1989-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |